Close Menu

NEW YORK (GenomeWeb) – Waters today reported that its fourth quarter revenues were up 9 percent compared to the year-ago period.

For the three months ended Dec. 31, 2017, Waters' total revenues increased to $687 million from $629 million in Q4 2016, besting the consensus analyst estimate of $669 million.

The effect of foreign currency translation boosted Q4 revenues by 3 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.